Theorem Clinical Research

Awards & Advancement

Jennifer Doudna, Emmanuelle Charpentier win award for biomedical research

Friday, June 27, 2014 12:53 PM

Johnson & Johnson has named Dr. Jennifer Doudna of the University of California at Berkeley and the Howard Hughes Medical Institute, and Dr. Emmanuelle Charpentier, of the Hannover Medical School and Helmholtz Center for Infection Research (HZI), Germany and the Laboratory for Molecular Infection Medicine Sweden (MIMS), Umea University, Sweden, the winners of the 2014 Dr. Paul Janssen Award for Biomedical Research. Their collaboration led to the discovery of a new method for precisely manipulating genetic information in ways that should produce new insights in health and disease, and may lead to the discovery of new targets for drug development.

More... »


St. Jude Children's Research Hospital names James R. Downing CEO

Friday, June 27, 2014 11:58 AM

St. Jude Children's Research Hospital has appointed James R. Downing, M.D., as its new CEO, effective July 15. Downing most recently was the deputy director, executive vice president and scientific director of the hospital. Downing's primary focus immediately upon assuming the CEO office will be to oversee a new era of clinical, research and infrastructure expansion throughout the St. Jude global network. He succeeds Dr. William E. Evans, who is retiring from the position after 10 years and returning full time to his long-standing pharmacogenomics research program at St. Jude.

More... »


HedgePath Pharmaceuticals adds three new board members

Thursday, June 26, 2014 03:36 PM

HedgePath Pharmaceuticals, a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, has announced that Stefan J. Cross, Dr. R. Dana Ono and W. Mark Watson, CPA, have been appointed to HedgePath's board of directors.

More... »

Kibow Biotech is a "Buzz of BIO" award winner

Thursday, June 19, 2014 02:52 PM

Kibow Biotech is winner of a 2014 BIO International Convention "Buzz of BIO Award," and is the first biotechnology company specializing exclusively in dietary supplement products to receive the honor during BIO's 29-year history. BIO is the world's largest trade association, representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the U.S. and more than 30 other nations. BIO member companies are involved in the R&D of innovative healthcare, agricultural, industrial and environmental biotechnology products.

More... »

Sorbent Therapeutics appoints two new board members

Thursday, June 19, 2014 02:27 PM

Sorbent Therapeutics, a biopharmaceutical company developing therapies for cardiovascular and renal diseases, has appointed Jay Shepard and William D. Waddill to the company's board of directors.

More... »

Sangamo BioSciences appoints H. Stewart Parker to its board of directors

Thursday, June 19, 2014 01:57 PM

Sangamo BioSciences announced the appointment of H. Stewart Parker to the company's board of directors. Parker, who founded and was president and CEO of Targeted Genetics, brings more than 30 years of experience in the biotechnology industry, including 16 years of specific experience in cell and gene therapy.

More... »

CSSi appoints Ronald Bukowski to New Medical and Clinical Advisory Board

Thursday, June 12, 2014 01:02 PM

CSSi, a provider of patient recruitment solutions for the clinical research industry, recently announced the formation of the company's Medical and Clinical Advisory Board (MCAB) and the appointment of Ronald M. Bukowski, M.D., as its chairman.

More... »

Kite Pharma appoints William Y. Go, Jeff Aycock senior directors

Thursday, June 12, 2014 12:54 PM

Kite Pharma, a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT) products for the treatment of cancer, has expanded Kite's R&D leadership team with the appointments of William Y. Go, M.D., Ph.D., as senior director, Clinical Development, and Jeff Aycock as senior director, Clinical Operations.

More... »

OptiNose adds three to operations, regulatory affairs and commercialization

Thursday, June 12, 2014 12:34 PM

OptiNose, a global specialty pharmaceuticals company, has announced three appointments to the company's senior management team.

More... »

Andrew S. Kraft named director of University of Arizona Cancer Center

Monday, June 9, 2014 10:44 AM

Dr. Andrew S. Kraft, a prostate cancer physician-scientist and cancer center administrator, has been named the Sydney E. Salmon endowed chair and director of the University of Arizona Cancer Center and associate vice president for oncology programs for the UA Health Sciences Center. In addition, Kraft joins the University as a tenured professor of medicine in the department of Medicine's Division of Hematology/Oncology and senior associate dean for translational research in the College of Medicine.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 15

WIRB-Copernicus Group acquires New England IRB

BBK Worldwide secures $3 million in private ἀnancingto accelerate its global and technological expansion

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs